AstraZeneca has unveiled late-stage data backing use of its triple combination therapy PT010 in patients with chronic obstructive pulmonary disease (COPD).
The Mahoney Institute for Neurosciences (MINS) at the University of Pennsylvania is pleased to announce an international call for submissions for the inaugural Rising Star Award in neuroscience research.